Lavaca Capital’s Organon & Co OGN Stock Holding History

Lavaca Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.7K	Buy	3,667 +3,515	+2,313%	+$42K	﹤0.01%	210
2026 Q1	$910	Buy	152 +97	+176%	+$730	﹤0.01%	280
2025 Q4	$394	Hold	55	–	–	﹤0.01%	282
2025 Q3	$587	Hold	55	–	–	﹤0.01%	265
2025 Q2	$532	Hold	55	–	–	﹤0.01%	263
2025 Q1	$819	Hold	55	–	–	﹤0.01%	242
2024 Q4	$821	Buy	+55	New	+$896	﹤0.01%	298
2022 Q1	–	Sell	-9,204	Closed	-$280K	–	197
2021 Q4	$280K	Sell	9,204 -118	-1%	-$3.84K	0.04%	139
2021 Q3	$306K	Sell	9,322 -1,478	-14%	-$47.3K	0.03%	128
2021 Q2	$327K	Buy	+10,800	New	+$356K	0.03%	122

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Lavaca Capital's OGN Position: Q2 2026 in Review

Lavaca Capital increased its Organon & Co (OGN) stake by 2,313% in Q2 2026, buying an estimated $42K and bringing the position to 3,667 shares worth $49.7K. The position accounts for ﹤0.01% of the portfolio, ranked #210.

Lavaca Capital first reported a position in OGN in Q2 2021 and has held it in 10 quarters since. The position peaked at $327K in Q2 2021. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Lavaca Capital held 3,667 shares of Organon & Co worth $49.7K as of Q2 2026.
Lavaca Capital bought 3,515 Organon & Co shares in Q2 2026, an estimated $42K.
Organon & Co made up ﹤0.01% of Lavaca Capital's portfolio in Q2 2026, its #210 holding.
Lavaca Capital first reported a position in Organon & Co in Q2 2021 and has held it in 10 quarters since.
Lavaca Capital's Organon & Co position peaked at $327K in Q2 2021.
633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.